P&G Health Share Price: Diwali Packing! **21%** Upar, Investors ko **₹160** ka Dhamakedar Dividend!

CONSUMER-PRODUCTS
Whalesbook Logo
AuthorRiya Kapoor|Published at:
P&G Health Share Price: Diwali Packing! **21%** Upar, Investors ko **₹160** ka Dhamakedar Dividend!
Overview

P&G Health ke liye third quarter solid raha! Unki sales **21%** badhkar **₹368 crore** ho gayi, thanks to new products like Livogen Iron Gummies. Aur kya? Investors ke liye **₹160** per share ka dividend bhi announce kiya hai, jisme **₹50** special payout hai!

📉 The Financial Deep Dive

Okay, toh P&G Health Limited (PGHL) ne apna Q3 results nikala hai jo December 31, 2025 ko end hua. Sabse badi baat, inki revenue mein 21% ka zabardast jump aaya hai, total ₹368 crore pahunch gaya. Yeh growth mili hai unke naye products ki wajah se, jaise ki Livogen Iron Gummies aur Neurobion Nerve Pain Relief Cream, aur unki supply chain bhi kaafi smooth chal rahi hai. Company ka Profit After Tax (PAT) is quarter mein ₹78 crore raha.

🎤 Management Commentary

MD Mr. Milind Thatte ne bataya ki company ka focus consumers ki needs ko samajhna hai. Yeh log bade brands banane, sahi tarike se market mein pahunchne aur science-based innovations par focus kar rahe hain. Goal hai ki apne trusted brands ke through sustainable growth aur value creation karein.

💰 Dividend Action

Shareholders ke liye ek aur achhi khabar hai! PGHL ne ₹160 per equity share ka interim dividend declare kiya hai FY 2025-26 ke liye. Isme ₹50 ka special dividend bhi included hai. Isse company ka confidence dikhta hai aur shareholders ko reward karne ka commitment bhi.

🚩 Risks & Outlook

Abhi tak company ne aage ke liye koi specific financial guidance nahi di hai, na hi balance sheet ya cash flow ke baare mein detailed jankari share ki hai. Toh future mein kya hone wala hai, iska exact idea lagana investors ke liye thoda mushkil hai. Naye products aur supply chain improvements par reliance hai, toh agar execution mein dikkat aayi toh performance par asar pad sakta hai. Zyada details ke liye investors ko future updates ka wait karna hoga.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.